Omidenepag Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Omidenepag, is a novel selective, non-prostanoid EP2 receptor agonist for the treatment of Glaucoma:

Omidenepag Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Omidenepag Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
Chemtour Biotech Co., Ltd	+8617327281506	market@chemtour.com	China	1460	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8617865335152	Mandy@hangyubiotech.com	China	10986	58
Shanghai Chaolan Chemical Technology Center	021-QQ：65489617 15618227136	Sales@ATKchemical.com	China	7295	58
Jinan Guoding Pharmaceutical Technology Co., Ltd.	15665775653	sales@guodingpharma.com	China	502	58
DC Chemicals	021-58447131 13564518121	sales@dcchemicals.com	China	9409	58
Guangzhou Younan Technology Co., Ltd	020-82000279 18988968278	sales@ubiochem.com	China	4297	58
cjbscvictory	13348960310 13348960310	3003867561@qq.com	China	10011	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58

---

• Omidenepag
• Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-
• 1187451-41-7